非酒精性脂肪性肝病诊断与治疗推荐意见(2006年11月修订)

• 作 者: 魏国华 范建高
• 机 构: 亚太地区非酒精性脂肪性肝病工作组,
• 出 处: 中华全科医师杂志
• 发表日期: 2007年04期
• 关键词: 代谢综合征 推荐意见 脂肪肝 肝病 调查对象 亦已 诊断标准 内脏性肥胖 脂肪性肝炎 空腹血糖

非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)为西方发达国家最常见的肝病,成人受累20%～30%。众多研究表明,脂肪肝亦已成为亚太地区的重要肝病,成人患病率10%～45%。尽管 NAFLD 的患病率因调查对象的年龄、性别、种族组成以及诊断标准的不同而有差异,但在过去的15年间,亚太地区 NAFLD 患病率增长的趋势与当地营养过剩、肥胖、糖尿病以及代谢综合征患病率增加趋

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the developed western countries. Adults suffer from 20% to 30% of the disease. Numerous studies show that fatty liver has also become an important liver disease in the Asia-Pacific region, with a prevalence of 10% -45% in adults. Although the prevalence of NAFLD varies according to the age, sex, ethnic composition, and diagnostic criteria of the respondents, the trend of increased prevalence of NAFLD in the Asia Pacific region over the past 15 years is related to the prevalence of overnutrition, obesity, diabetes, The prevalence of metabolic syndrome increased